Suppression of mitochondrial ATPase inhibitor protein (IF1) in the liver of late septic rats

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1767, Issue 7, 2007, Pages 888-896

  Huang, Li Ju ^a   Hsu, Chin ^a   Tsai, Tsen Ni ^a   Wang, Shu Jung ^a   Yang, Rei Cheng ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

IF1; Liver; Mitochondrial F0F1 ATPase; Sepsis

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; MESSENGER RNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE INHIBITOR PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; CYTOPLASM; ENZYME ACTIVITY; IMMUNOPRECIPITATION; LIVER DYSFUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; IMMUNOPRECIPITATION; LIVER; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; PROTEIN SUBUNITS; PROTEINS; RATS; RNA, MESSENGER; SEPSIS;

RATTUS;

EID: 34447104809     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2007.03.009     Document Type: Article

References (39)

1. Guidet B., Aegerter P., Gauzit R., Meshaka P., Dreyfuss D., and CUB-Rea Study Group. Incidence and impact of organ dysfunctions associated with sepsis. Chest 127 (2005) 942-951
2. Anderson R.N., and Smith B.L. Deaths: leading causes for 2002. Natl. Vital. Stat. Rep. 53 (2005) 1-89
3. Mullins R.J., Mann N.C., and Hedges J.R. Adequacy of hospital discharge status as a measure of outcome among injured patients. JAMA 279 (1998) 1727-1731
4. Szabo G., Romics Jr. L., and Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6 (2002) 1045-1066
5. Ayala A., Evans T.A., and Chaudry I.H. Does hepatocellular injury in sepsis involve apoptosis?. J. Surg. Res. 76 (1998) 165-173
6. Romics Jr. L., Frendl G., and Szabo G. Cellular and molecular changes of the liver in sepsis and in systemic inflammatory response syndrome (SIRS). Orv. Hetil. 144 (2003) 499-506
7. Brealey D., and Singer M. Mitochondrial dysfunction in sepsis. Curr. Infect. Dis. Resp. 5 (2003) 365-371
8. Fink M.P. Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Cirt. Care Clin. 17 (2001) 219-237
9. Hart D.W., Gore D.C., Rinehart A.J., and Asimakis G.K. Sepsis-induced failure of hepatic energy metabolism. J. Surg. Res. 115 (2003) 139-147
10. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Copper C.E., and Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 36l0 (2002) 219-223
11. Couser E.D., Julian M.W., Blaho D.V., and Pfeiffer D.R. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit. Care Med. 30 (2002) 276-284
12. Brealey D., Karyampudi S., Jaques T.S., Novelli M., Stidwill R., Taylor V., Smolenski R.T., and Singer M. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 286 (2004) R491-R497
13. Hsieh Y.C., Hsu C., Yang R.C., Lee P.Y., Hsu H.K., and Sun Y.M. Isolation of bona fide differentially expressed genes in the 18-h sepsis liver by suppression subtractive hybridization. Shock 21 (2004) 549-555
14. Lebowitz M.S., and Pedersen P.L. Regulation of the mitochondrial ATP synthase/ATPase complex: cDNA cloning, sequence, overexpression, and secondary structural characterization of a functional protein inhibitor. Arch. Biochem. Biophys. 301 (1993) 64-70
15. 1 synthase. Eur. J. Biochem. 240 (1996) 461-467
16. Wichterman K.A., Baue A.E., and Chaudry I.H. Sepsis and septic shock-An review of laboratory models and proposal. J. Surg. Res. 29 (1980) 189-201
17. Sum Y.M., Yang S.L., Jin Y.W., Wu S.N., Hsu H.K., and Liu M.S. Kinetic studies of protein kinase A in rat liver during early sepsis. Gaoxiong Yixue Kexue Zazhi 9 (1993) 80-88
18. Ekedahl J., Joseph B., Grigorive M.Y., Müller M., Magnusson C., Lewensohn R., and Zhivotovsky B. Expression of inhibitor of apoptosis protein in small- and non-small-cell lung carcinoma cells. Exp. Cell Res. 279 (2002) 277-290
19. Wiltshire C., Maisushita M., Tsukada S., Gillespie David A.F., and May Gerhard H.W. A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem. J. 367 (2002) 577-585
20. Wei Y.H., Ding W.H., and Wei R.D. Biochemical effects of RP toxin on rat liver mitochondrial respiration and oxidative phosphorylation. Arch. Biochem. Biophys. 230 (1984) 400-411
21. Drew B., and Leeuwenburgh C. Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 285 (2003) R1259-R1268
22. Ko Y.H., Hullihen J., Hong S., and Pedersen P.L. Mitochondrial F(0)F(1) ATP synthase. Subunit regions on the F1 motor shielded by F(0), Functional significance, and evidence for an involvement of the unique F(0) subunit F(6). J. Biol. Chem. 275 (2000) 32931-32939
23. Zanotti F., Raho G., Gaballo A., and Papa S. Inhibition and anchoring domain in the ATPase inhibitor protein IF1 of bovine heart mitochondrial ATP synthase. J. Bioenerg. Biomembr. 36 (2004) 447-457
24. Harbresht B.H., Zenati M.S., Doyte H.R., McMichael J., Townsend R.N., Clancy K.D., and Peitzman A.B. Hepatic dysfunction increases length of stay and risk of death after injury. J. Trauma 5 (2002) 517-523
25. Fink M.P. Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?. Crit. Care Clin. 18 (2002) 165-175
26. Szabo G., Romics Jr. L., and Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6 (2002) 1045-1066
27. Taylor D.E., Ghio A.J., and Piantadosi C.A. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch. Biochem. Biophys. 316 (1995) 70-76
28. Suliman H.B., Carraway M.S., and Piantadosi C.A. Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am. Respir. Crit. Care Med. 167 (2003) 570-579
29. Kroemer G., Zamzani N., and Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 18 (1997) 44-51
30. 1-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolyase activity. Am. J. Physiol.: Circ. Physiol. 287 (2004) H1747-H1755
31. 1-ATPase. Circulation 91 (1995) 2810-2818
32. Klein G., Satre M., Dianoux A.C., and Vignais P.V. Radiolabeling of natural adenosine triphosphatase inhibitor with phenyl (14C) isothiocyanate and study of its interaction with mitochondrial adenosine triphosphatase. Localization of inhibitor binding sites and stoichiometry of binding. Biochemistry 19 (1980) 2919-2925
33. Yamada D.W., and Huzel N.J. Distribution of the ATPase inhibitor proteins of mitochondria in mammalian tissues including fibroblasts from a patient with Luft's disease. Biochim. Biophys. Acta 1139 (1992) 143-147
34. Banerjee A., Linscheer W.G., Chiji H., Murthy U.K., Cho C., Nandi J., and Chan S.H. Induced of an ATPase inhibitor protein by propylthiouracil and protection against paracetamol (Acetaminophen) hepatotoxicity in the rat. Br. J. Pharmacol. 124 (1998) 1041-1047
35. 1-ATPase. Biochim. Biophys. Acta 1458 (2000) 343-355
36. 0ATPase upon de-energization of mitochondria. J. Biochem. (Tokyo) 113 (1993) 350-354
37. Jackson P.J., and Harris D.A. The mitochondrial ATP synthase inhibitor protein binds near the C-terminus of the F1 beta-subunit. FEBS Lett. 229 (1988) 224-228
38. Minauro-Sanmiguel F., Bravo C., and Garcia J.J. Cross-linking of the endogenous inhibitor protein (IF1) with rotor (gamma, epsilon) and stator (alpha) subunits of the mitochondrial ATP synthase. J. Bioenerg. Biomembr. 34 (2002) 433-443
39. Bravo C., Minauro-Sanmiguel F., Morales-Rios E., Rodriguez-Zavala J.S., and Garcia J.J. Overexpression of the inhibitor protein IF1 in AS-30D hepatoma produces a higher association with mitochondrial F1F0 ATP synthase compared to normal rat liver: functional and cross-linking studies. J. Bioenerg. Biomembr. 36 (2004) 257-264